The provided programs implements the EORTC Scoring System for grade III
glioma (anaplastic oligodendroglioma or oligoastrocytoma) as published in the
scientific article:
New clinical, pathological and molecular prognostic models and calculators in
patients with locally diagnosed anaplastic oligodendroglioma or
oligoastrocytoma. A prognostic
factor analysis of EORTC Brain Tumor Group Study 26951.
Under review.
They allow the user to estimate the median progression free survival,
median survival , probability of progression free survival at 2 years, the
probability of survival at 5 years in patients with anaplastic oligodendroglioma
or oligoastrocytoma based on 9 different prognostic factors: treatment
administered after surgery or biopsy, patient age , tumor location, extent of resection with
confirmation, WHO performance status, endothelial abnormalities, necrosis,
1p/19q codeletion status, IDH1
mutation status.
Get access to the prognostic calculators here